Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
[Intra-family transmission of human T-cell lymphotropic virus-1 (HTLV-1) in a cohort of HTLV-1-positive patients (Benin)]
Bull Soc Pathol Exot. 1995;88(3):79-80. Unique Identifier : AIDSLINE MED/96150674 Houinato D; Verdier M; Josse R; Foundohou J; Preux PM; Avode G; Zohoun T; Denis F; Dumas M; Institut d'Epidemiologie neurologique et de neurologie; tropicale, Limoges.
Abstract:
We are reporting the results of a familial study carried out in Benin in March 1994 within a cohort of HTLV-1 positive subjects. This study aims at appraising the different modes of intra-familial transmission of this retrovirus. The study has included 212 persons: 33 seropositive subjects (identified during two previous seroprevalence surveys and followed up since 1991), and 179 members of their families. Blood specimens have been taken from each of these subjects. Sera have been screened for HTLV-1 antibodies by ELISA test and positive results confirmed by Western blot test. Out of 18 children born during the follow up period, 2 cases of seroconversion have been observed. One case of seroconversion has also been noted among the 17 couples in which either of the spouses is seropositive. Among the 136 children of the cohort: 17.8% of them are HTLV-1 positive when both parents are seropositive 26.1% if the mother only is seropositive and 0% if the father only is seropositive. The incidence rate in this cohort is estimated to be 0.43%. These data relative to the intra-familial transmission of HTLV-1 in Benin appear to be consistent with those previously reported in Japan.
Keywords: Benin Blotting, Western Child Cohort Studies *Disease Transmission, Vertical English Abstract Enzyme-Linked Immunosorbent Assay Fathers Female Follow-Up Studies Human HTLV-I/ISOLATION & PURIF HTLV-I Antibodies/BLOOD HTLV-I Infections/GENETICS/*TRANSMISSION Incidence Male Mothers Seroepidemiologic Methods JOURNAL ARTICLE 960530
M9651050
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.